Abstract
In an effort to improve the therapeutic efficacy of methotrexate (MTX), we prepared the hyaluronic acid–MTX conjugate for targeted therapy of rheumatoid arthritis (RA). Owing to the pH-sensitive nature of the conjugate, MTX was rapidly released under the mildly acidic conditions, similar to the environment of inflamed synovial tissue in RA.
| Original language | English |
|---|---|
| Pages (from-to) | 7632-7635 |
| Number of pages | 4 |
| Journal | Chemical Communications |
| Volume | 50 |
| Issue number | 57 |
| DOIs | |
| State | Published - 19 Jun 2014 |
Fingerprint
Dive into the research topics of 'A hyaluronic acid–methotrexate conjugate for targeted therapy of rheumatoid arthritis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver